Moon, Do Chang <br/><br/>
Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer.  [electronic resource] 

 -  Yonsei medical journal  Sep 2016 
 - 1124-30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1976-2437 
<br/><br/><label>Standard No.: </label>10.3349/ymj.2016.57.5.1124  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Erlotinib Hydrochloride--administration & dosage<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Pancreatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Survival Rate<br/>Young Adult<br/>Gemcitabine